About List Biological Laboratories
List Biological Laboratories is a Healthcare company based in Campbell (United States) founded in 1978, and was acquired by Genome & Company in September 2021. It specializes in the production of research reagents. List Biological Laboratories has raised $48.4 million across 2 funding rounds from investors including Korea Investment Holdings, Genome & Company and DSC Investment. List Biological Laboratories offers products and services including Bacterial Toxins, Bacterial Polysaccharides, Recombinant Proteins, and Live Biotherapeutics. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is LIST BIOLOGICAL LABORATORIES, INC. Its competitors include PrognomiQ, ACRO Biosystems and Ansh Labs; 1 of its 3 listed competitors has raised funding.
Company details
Specializes in the production of reagents for research and custom laboratory services. The company product line includes anthrax toxins, antisera antibodies, botulinum toxins, cholera toxins, clostridial toxins, other difficile toxins, Diphtheria Toxin CRM Exotoxin, Peptides, Native Substrates Receptors, Lipopolysaccharides, Pertussis Toxins Virulence Factors, Shiga Toxins, Staphylococcal Toxins, Tetanus Toxins Related Products, Toxoids Vaccine Carrier Proteins and Adjuvants.
- Headquarters Campbell, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website listlabs.com
- Social LinkedIn X Facebook YouTube
- Acquired by Genome & Company (Sep 2021)
- Legal Name List Biological Laboratories, Inc
- Total Equity Funding$48.4M (USD)
in 2 rounds
- Latest Funding Round$17.4M (USD), Private Equity Round
Mar 2022
- InvestorsKorea Investment Holdings
& 3 more
- Acquired byGenome & Company
(Sep 2021)
Products & Services of List Biological Laboratories
List Biological Laboratories offers a comprehensive portfolio of products and services, including Bacterial Toxins, Bacterial Polysaccharides, Recombinant Proteins, and Live Biotherapeutics.
High-purity toxins for disease studies and therapeutic tools.
Compounds for vaccine development and research applications.
Proteins for clinical and research use in therapies.
Manufacturing for microbiome-based therapeutic products.
Apps and channels of List Biological Laboratories
its YouTube channel List Biological Laboratories, Inc. has 32 subscribers and 10 videos.
Videos from List Biological Laboratories
The most watched videos on List Biological Laboratories's YouTube channel, List Biological Laboratories, Inc. (32 subscribers). Click a video to play it here.
More on List Biological Laboratories, Inc..
Funding Insights of List Biological Laboratories
List Biological Laboratories has successfully raised a total of $48.4M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $17.4 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $48.4M
- Total Rounds 2
- Last Round Private Equity Round β $17.4M
- First Round $31M
(Dec 2021)
- Investors Count 3
All 2 funding rounds of List Biological Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | $17.4M | Private Equity Round | β | β | β |
| Dec 2021 | $31M | Private Equity Round | β | DSC Investment, Korea Investment Holdings | β |
4 investors in total: 4 institutional.
Investors in List Biological Laboratories
List Biological Laboratories has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Korea Investment Holdings, Genome & Company and DSC Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital is invested primarily in South Korean startups. | 2012 | dscinvestment.com | Seoul, South Korea | |
Investment holding firm established in Seoul in 2003. | 2003 | koreainvestment.com | Seoul, South Korea | |
Operates as an investment management firm handling diversified funds and portfolios. | 2006 | koreavalueasset.com | Seoul, South Korea | |
Microbiome-based immuno-oncology drugs are developed using proprietary technology. | 2015 | genomecom.co.kr | Seongnam-si, South Korea |
Investor details for List Biological Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of List Biological Laboratories
12 people are tracked at List Biological Laboratories (4 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Gary Henderson | Director Of Sales And Business Development | Leadership |
Nuria Gonzalez Montalban | Director Of Biologics Development | Leadership |
Stacy Burns-Guydish | President | Leadership |
Joseph Yu | Sr. Director, Development And Manufacturing | Leadership |
Steven Elayda | Manufacturing Associate Iii, Purification | Team |
Shivangi Darji | Microbiologist II | Team |
Carina Rocchio | Laboratory Manager | Team |
Mary Nguyen | Fermentation Specialist II | Team |
Matthew Aguilar | Production Biochemist 2 | Team |
Kendall Kato | Production Operations Manager | Team |
Todd Christian | Process Development Manager | Team |
Monica Straube | Fermentation Specialist III | Team |
Complete people profiles for List Biological Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of List Biological Laboratories
4 dated milestones of List Biological Laboratories across 44 years, from founding to its latest funding, stage changes and deals.
- Founded List Biological Laboratories is founded.
- Exit Acquired by Genome & Company.
- Funding First funding round of $31.0M.
- Funding Latest funding round, Private Equity Round, of $17.4M.
Competitors of List Biological Laboratories
List Biological Laboratories has 3 listed competitors in our database, 1 of them funded. They include PrognomiQ, ACRO Biosystems and Ansh Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prognomiq.com | 2020 | San Mateo, United States | $90.36M | 24 | Developer of tests for the detection and treatment of cancer and other diseases | |
| acrobiosystems.com | 2016 | Newark, United States | 22 | Recombinant proteins are manufactured to support cancer immunotherapy efforts. | ||
| anshlabs.com | 2010 | Webster, United States | 33 | Immunoassay reagents and kits are developed for life science research. |
Detailed competitors of List Biological Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of List Biological Laboratories
The website of List Biological Laboratories (listlabs.com) receives about 7.6K visits a month.
- Monthly visits7.6K
▲ 17.9% vs previous month
Websites whose visitors overlap most with List Biological Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
biologylab.awlonline.com | biologylab.awlonline.com | 100% | β | ||
| abdesignlabs.com | 97% | 4.7K | #4,128,811 | View details | |
| bioscience.co.uk | 92% | 58K | #534,137 | View details | |
| lampire.com | 86% | #2,833,014 | View details | ||
| embl.org | 86% | 302.2K | #140,553 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 15 similar websites and full traffic analytics for List Biological Laboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as List Biological Laboratories (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about List Biological Laboratories
Complete news archive for List Biological Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about List Biological Laboratories
List Biological Laboratories was founded in 1978 and raised its 1st funding round 43 years after it was founded.
List Biological Laboratories is headquartered in Campbell, United States. It is registered at Campbell, California, United States.
List Biological Laboratories is a funded company, having raised a total of $48.4M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $31M, raised on Dec 2021.
Specializes in the production of reagents for research and custom laboratory services. The company product line includes anthrax toxins, antisera antibodies, botulinum toxins, cholera toxins, clostridial toxins, other difficile toxins, Diphtheria Toxin CRM Exotoxin, Peptides, Native Substrates Receptors, Lipopolysaccharides, Pertussis Toxins Virulence Factors, Shiga Toxins, Staphylococcal Toxins, Tetanus Toxins Related Products, Toxoids Vaccine Carrier Proteins and Adjuvants.
List Biological Laboratories's top competitors include PrognomiQ, ACRO Biosystems and Ansh Labs.
List Biological Laboratories offers Bacterial Toxins, Bacterial Polysaccharides, Recombinant Proteins, and Live Biotherapeutics.
List Biological Laboratories has 4 investors. Key investors include Korea Investment Holdings, Genome & Company, DSC Investment, and Korea Investment Value Asset Management.
List Biological Laboratories operates through List Biological Laboratories, Inc.
Yes. List Biological Laboratories was acquired by Genome & Company in September 2021.

